Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo

Circulation Research

Volumn 85, Issue 4, 1999, Pages 377-385

  Nathan, Lauren ^a   Pervin, Shehla ^a   Singh, Rajan ^a   Rosenfeld, Michael ^b   Chaudhuri, Gautam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Estradiol; Estrogen; Monocyte adhesion; Vascular cell adhesion molecule 1

Indexed keywords

ESTRADIOL; LYSOPHOSPHATIDYLCHOLINE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CELL MIGRATION; ENDOTHELIUM CELL; FEMALE; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SEX DIFFERENCE;

EID: 0033588352     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.4.377     Document Type: Article

References (51)

1. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med. 1976;85:447-452.
2. Bush TL. The epidemiology of cardiovascular disease in postmenopausal women. Ann N Y Acad Sci. 1990;592:263-271.
3. Master AM, Dack S, Jafee HL. Age, sex and hypertension in myocardial infarction due to coronary occlusion. Arch Intern Med. 1939;64:767-786.
4. McGee D. The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. In: WB Kannel, T Gordon, eds. Framingham Study 18-Year Followup: An Epidemioiogical Investigation of Cardiovascular Disease. Washington, DC: National Institutes of Health, 1973;74-618.
5. Hamm TE, Kaplan JR, Clarkson TB, Bullock BC. Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis. 1983;48:221-233.
6. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Gender differences in atherosclerosis: possible role of nitric oxide. J Cardiovasc Pharmacol. 1995;26:792-802.
7. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
8. Green A, Bain C. Epidemiological overview of oestrogen replacement and cardiovascular disease. Baillieres Clin Endocrinol Metab. 1993;7: 95-112.
9. Adams MR, Kaplan JR, Clarkson TB, Koritnik DR. Ovariectomy, social status and atherosclerosis in cynomolgus monkeys. Arteriosclerosis. 1985;5:192-200.
10. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
11. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
12. Haarbo J, Fischer Hansen B, Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits. Acta Pathol Microbiol Immunol Scand. 1991;99:721-727.
13. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85: 1260-1266.
14. Teinhoven AV. Cyclic reproductive phenomena. In: Teinhoven AV, ed. Reproductive Physiology of Vertebrates. Philadelphia, Pa: WB Saunders Co Inc; 1968:269-296.
15. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:9-23.
16. de Cupis A, Noonan P, Pirani P, Ferrera A, Clerico L, Favoni RE. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. Br J Pharmacol. 1995;116: 2391-2400.
17. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986;231:1150-1154.
18. Puppione DL, Charugundla S. A microprecipitation technique suitable for measuring alpha-lipoprotein cholesterol. Lipids. 1994;29:595-597.
19. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583-595.
20. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 1986;129:101-123.
21. Lu JKH, Gilman DP, Meldrum DR, Judd HL, Sawyer CH. Relationship between circulating estrogens and the central mechanisms by which ovarian steroids stimulate luteinizing hormone secretion in aged and young female rats. Endocrinology. 1981;108:836-841.
22. Brenner PF, Guerrero R, Cekan Z, Diczfalusy E. Radioimmunoassay method for sex steroids in human plasma. Steroids. 1973;22:775-794.
23. Bayard F, Clamens S, Delsol G, Blaes N, Maret A, Faye JC. Oestrogen synthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells. Ciba Found Symp. 1995;191:122-132.
24. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57: 791-804.
25. Territo MC, Berliner JA, Almada L, Ramirez R, Fogelman AM. β-Very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Arteriosclerosis. 1989;9:824-828.
26. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R. Direct expression of cloning of vascular cell adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59:1203-1211.
27. Rice GE, Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/ CD18-independent adhesion mechanism. J Exp Med. 1990;171: 1369-1374.
28. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251: 788-791.
29. Cybulsky MI, Fries JW, Williams AJ, Sultan P, Eddy R, Byers M, Shows T, Gimbrone MA Jr, Collins T. Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci USA. 1991;88:7859-7863.
30. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990;60:577-584.
31. Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, Derse-Anthony CP, Klunk D, Schleimer RP. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med. 1991;173:1553-1557.
32. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13:197-204.
33. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol. 1993;143:1551-1559.
34. Tang M, Abplanaip W, Ayres S, Subbiah MT. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metab Clin Exp. 1996;45:411-414.
35. Subbiah MT, Kessel B, Agrawal M, Rajan R, Abplanaip W, Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab. 1993;77:1095-1097.
36. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA. 1988;85:2805-2809.
37. Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D. Oxidative modification of beta-very low density lipoprotein: potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 1989;9:398-404.
38. Portman OW, Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 1969;10:158-165.
39. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
40. Nakai K, Itoh C, Hotta K, Itoh T, Yoshizumi M, Hiramori K. Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 beta in human umbilical vein endothelial cells. Life Sci. 1994;54:PL221-PL227.
41. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17 beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 1996;98:36-42.
42. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1 and vascular cell adhesion molecule type 1. J Clin Invest. 1994;93:17-25.
43. Aziz KE, Wakefield D. Modulation of endothelial cell expression of ICAM-1: E-selectin and VCAM-1 by beta-estradiol, progesterone and dexamethasone. Cell Immunol. 1996;167:78-85.
44. Colburn P, Buonassisi V. Estrogen-binding-sites in endothelial cell cultures. Science. 1978;201:817-819.
45. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, Greene GL, Schnaper HW. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996;94:1402-1407.
46. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9:619-626.
47. Inoue S, Hoshino S, Miyoshi H, Akishita M, Hosoi T, Orimo H, Ouchi Y. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action in vascular smooth muscle cells. Biochem Biophys Res Commun. 1996;219:766-772.
48. Pervin S, Singh R, Rosenfeld M, Chaudhuri G, Nathan L. Estradiol suppresses MCP-1 expression in vivo: implications for atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1575-1582.
49. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD, Lobb R, Alpers CE. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993;92:945-951.
50. Lendon CL, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis. 1991;87:87-90.
51. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 1996;7:330-335.